Asset Visibility: Pharma Industry Track and Trace Regulations in Asia-Pacific
Price:
Starting at USD 3,000
Publish Date: 18 Apr 2022
Code: PT-2577
Research Type: Presentation
Pages: 22
Actionable Benefits
- Strategic planning for pharmaceutical vendors and distributors for changes in serialization regulations.
- Gain insight into scale and scope of current regulations.
- Guidance into proposed future regulatory changes.
Research Highlights
- Focus on emerging markets (China, India, and Malaysia) as well as developed markets (South Korea and Japan).
- Identifies variation between region-level trends and country-level regulations.
- Comparison and analysis of different levels of serialization.
Critical Questions Answered
- What is the timeline for implementation of serialization regulations?
- What are the key data standards and mandates for traceability?
- How are international standards like GS1 leveraged in national regulations?
Who Should Read This?
- Strategy planners and advisors within the pharmaceutical and supporting logistics industry.
- Managers aiming to identify regulatory requirements of their operations.
- For serialization software and hardware providers to assess regulatory impact on the pharmaceutical market.
Companies Mentioned
Table of Contents
Executive Summary
Key Objectives
Serialization Data Tables
Global Regulatory Environment
National Regulations and International Standards
Summary of Proposed System
Regional Regulatory Environment
Compliance: Mandates versus Voluntary Best Practices
Reporting Requirements
Suppliers/Third Party Logistics Responsible for Track & Trace
Good Distribution Practices
Penalties and Fines
Scale and Scope of Implementations
Items Subject to Track & Trace
Future Amendments Proposed
Conclusion
Definitions and Abbreviations
Companies Mentioned
- Alibaba Group
- GS1